Monish S. Lavu MHM, Joshua R. Porto MS, Christian J. Hecht II, David C. Kaelber MD, PhD, MPH, Peter K. Sculco MD, Nathanael D. Heckmann MD, Atul F. Kamath MD, MBA
{"title":"回复致编辑的信:为什么 \"胰高血糖素样肽 1 受体激动剂处方患者骨关节炎和全关节关节置换术五年进展发生率 \"与之前的随机对照研究有所不同?","authors":"Monish S. Lavu MHM, Joshua R. Porto MS, Christian J. Hecht II, David C. Kaelber MD, PhD, MPH, Peter K. Sculco MD, Nathanael D. Heckmann MD, Atul F. Kamath MD, MBA","doi":"10.1016/j.arth.2024.08.036","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":51077,"journal":{"name":"Journal of Arthroplasty","volume":"39 12","pages":"Pages e70-e71"},"PeriodicalIF":3.4000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Reply to the Letter to the Editor: Why Did the “Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists” Differ From the Previous Randomized Controlled Study?\",\"authors\":\"Monish S. Lavu MHM, Joshua R. Porto MS, Christian J. Hecht II, David C. Kaelber MD, PhD, MPH, Peter K. Sculco MD, Nathanael D. Heckmann MD, Atul F. Kamath MD, MBA\",\"doi\":\"10.1016/j.arth.2024.08.036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":51077,\"journal\":{\"name\":\"Journal of Arthroplasty\",\"volume\":\"39 12\",\"pages\":\"Pages e70-e71\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-11-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Arthroplasty\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0883540324008805\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ORTHOPEDICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arthroplasty","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0883540324008805","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
Reply to the Letter to the Editor: Why Did the “Five-Year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 Receptor Agonists” Differ From the Previous Randomized Controlled Study?
期刊介绍:
The Journal of Arthroplasty brings together the clinical and scientific foundations for joint replacement. This peer-reviewed journal publishes original research and manuscripts of the highest quality from all areas relating to joint replacement or the treatment of its complications, including those dealing with clinical series and experience, prosthetic design, biomechanics, biomaterials, metallurgy, biologic response to arthroplasty materials in vivo and in vitro.